ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 119915 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 119915; 2) Community: the network communities that were significantly associated with the response to NSC 119915; 3) Molecule: the relationships between components within communities and NSC 119915; 4) MDR: the compounds that were significantly associated with the NSC 119915.

NSC Compound Enrichment Correlation
NSC 667909 Null 0.022188614181866 0.054600021
NSC 669728 Null 0.022188614181866 0.17791243
NSC 670121 11-Hydroxy aclacinomycin A 0.022188614181866 0.17078458
NSC 685285 Null 0.022188614181866 0.032644153
NSC 694509 Null 0.022188614181866 0.10992783
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.022188614181866 0.24235907
NSC 718781 Erlotinib hydrochloride 0.022188614181866 -0.20253404
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.022188614181866 0.24801176
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.022188614181866 0.030625185
NSC 748559 4-(4-chlorophenyl)-1-3-[(E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]phenyl-2,3-dihydro-1H-2-imidazolone 0.022188614181866 0.29337908
Total:82  Current:44    [First] [Prev] [Next] [Last]